Companies
RNS
Signals
Macro
AI Chat
Research
Indices
Ticker TV
Events
Commodities
Currencies
Footer menu
⌘K
Open sidebar
Developer Portal
News
Services
Iq-Ai Limited (IQAI) RNS Announcements | Ticker
/
Equities
/
XLON
/
IQAI
/
RNS
Former ticker.
Iq-Ai Limited now trades as
IBAI
(IMAGING BIOMETRICS LIMITED).
Overview
Share Price
RNS
Trades
Short Interest
Directors
Holdings
Iq-Ai Limited RNS
/
Equities
/
XLON
/
IQAI
/
RNS
Former ticker.
Iq-Ai Limited now trades as
IBAI
(IMAGING BIOMETRICS LIMITED).
Overview
Share Price
RNS
Trades
Short Interest
Directors
Holdings
Iq-Ai Limited RNS
Add to watchlist
Date
Time
Date
Title
Title
(filtered)
27/05/25
07:00:15
27 May 2025
Change of Name
Change of Name
22/05/25
14:23:17
22 May 2025
Result of AGM
Result of AGM
02/05/25
07:29:01
2 May 2025
Application: FDA Breakthrough Therapy Designation
Application: FDA Breakthrough Therapy Designation
29/04/25
10:49:12
29 Apr 2025
Notice of AGM
Notice of AGM
25/04/25
13:46:13
25 Apr 2025
Publication of Annual Report
Publication of Annual Report
11/04/25
15:32:25
11 Apr 2025
Promising Preliminary Results of Phase 1 Study
Promising Preliminary Results of Phase 1 Study
18/03/25
10:38:02
18 Mar 2025
Placing to raise £250,000
Placing to raise £250,000
03/02/25
07:00:06
3 Feb 2025
IB Expands Distribution with Blackford
IB Expands Distribution with Blackford
22/01/25
07:00:05
22 Jan 2025
Operations Update
Operations Update
10/01/25
07:49:29
10 Jan 2025
IB and Prism Secure First Installation
IB and Prism Secure First Installation
20/11/24
07:00:02
20 Nov 2024
Imaging Biometrics Expands Distribution
Imaging Biometrics Expands Distribution
19/11/24
11:27:03
19 Nov 2024
Board Changes
Board Changes
05/11/24
07:00:02
5 Nov 2024
New Patent Application and Trading Update
New Patent Application and Trading Update
15/10/24
10:28:36
15 Oct 2024
Holding(s) in Company
Holding(s) in Company
15/10/24
07:00:09
15 Oct 2024
IQ-AI Issues Letter to Shareholders
IQ-AI Issues Letter to Shareholders
14/10/24
12:08:15
14 Oct 2024
Holding(s) in Company
Holding(s) in Company
14/10/24
12:05:29
14 Oct 2024
PDMR dealing and TR1 announcement
PDMR dealing and TR1 announcement
11/10/24
10:42:37
11 Oct 2024
Acquisition of Interest by Braveheart
Acquisition of Interest by Braveheart
13/08/24
14:53:23
13 Aug 2024
Half-year Report
Half-year Report
25/06/24
09:59:49
25 Jun 2024
IB Opens Expanded Access Program
IB Opens Expanded Access Program
14/06/24
08:38:49
14 Jun 2024
Clinical Trial Updates
Clinical Trial Updates
29/05/24
15:08:33
29 May 2024
Result of AGM
Result of AGM
23/05/24
07:00:12
23 May 2024
Major East Coast Health System Chooses IB Nimble
Major East Coast Health System Chooses IB Nimble
20/05/24
07:10:27
20 May 2024
Second FDA Rare Pediatric Disease Designation
Second FDA Rare Pediatric Disease Designation
17/05/24
07:00:08
17 May 2024
IB Software Enhances Clinical Decision-Making
IB Software Enhances Clinical Decision-Making
10/05/24
08:15:34
10 May 2024
Rare Pediatric Disease Designation Granted to GaM
Rare Pediatric Disease Designation Granted to GaM
02/05/24
12:47:42
2 May 2024
IB Announces Expanded Access Program for GaM
IB Announces Expanded Access Program for GaM
29/04/24
15:26:10
29 Apr 2024
Publication of Annual Report
Publication of Annual Report
05/03/24
07:00:11
5 Mar 2024
Grant of Options
Grant of Options
01/03/24
08:22:06
1 Mar 2024
Holding(s) in Company
Holding(s) in Company
01/03/24
08:20:36
1 Mar 2024
Holding(s) in Company
Holding(s) in Company
26/02/24
07:00:03
26 Feb 2024
Result of Broker Option and Total Voting Rights
Result of Broker Option and Total Voting Rights
22/02/24
07:00:06
22 Feb 2024
Placing and Broker Option
Placing and Broker Option
09/02/24
12:49:51
9 Feb 2024
FDA Application Update
FDA Application Update
02/02/24
08:39:32
2 Feb 2024
IB awarded a $100,000 grant
IB awarded a $100,000 grant
22/01/24
10:05:43
22 Jan 2024
Holding(s) in Company
Holding(s) in Company
15/01/24
07:01:00
15 Jan 2024
Director Dealings and Conversion of CLNs
Director Dealings and Conversion of CLNs
15/01/24
07:00:05
15 Jan 2024
Holding(s) in Company
Holding(s) in Company
10/01/24
07:00:01
10 Jan 2024
IB Launching an Expanded Access Program for GaM
IB Launching an Expanded Access Program for GaM
19/12/23
14:29:45
19 Dec 2023
Imaging Biometrics granted FDA “Fast-Track”
Imaging Biometrics granted FDA “Fast-Track”
05/12/23
10:58:08
5 Dec 2023
IQ-AI Announces Positive Interim Phase 1 Results
IQ-AI Announces Positive Interim Phase 1 Results
20/11/23
13:42:56
20 Nov 2023
Holding(s) in Company
Holding(s) in Company
09/11/23
11:38:50
9 Nov 2023
Director Dealing and Conversion of CLNs
Director Dealing and Conversion of CLNs
08/11/23
10:59:44
8 Nov 2023
Application for Pediatric Rare Disease Designation
Application for Pediatric Rare Disease Designation
06/11/23
13:02:11
6 Nov 2023
Holding(s) in Company
Holding(s) in Company
18/10/23
14:29:47
18 Oct 2023
Update Regarding Imaging Biometrics LLC
Update Regarding Imaging Biometrics LLC
13/10/23
08:55:09
13 Oct 2023
IB Letter to Shareholders
IB Letter to Shareholders
09/10/23
07:00:14
9 Oct 2023
Orphan Drug Status to GaM and Total Voting Rights
Orphan Drug Status to GaM and Total Voting Rights
03/10/23
11:30:18
3 Oct 2023
Holding(s) in Company
Holding(s) in Company
19/09/23
14:32:20
19 Sept 2023
IQ-AI shares cease trading on the OTCQB
IQ-AI shares cease trading on the OTCQB
Showing 1–50 of 105 announcements
1
2
3
Next
Date
Time
Date
Title
Title
(filtered)
27/05/25
07:00:15
27 May 2025
Change of Name
Change of Name
22/05/25
14:23:17
22 May 2025
Result of AGM
Result of AGM
02/05/25
07:29:01
2 May 2025
Application: FDA Breakthrough Therapy Designation
Application: FDA Breakthrough Therapy Designation
29/04/25
10:49:12
29 Apr 2025
Notice of AGM
Notice of AGM
25/04/25
13:46:13
25 Apr 2025
Publication of Annual Report
Publication of Annual Report
11/04/25
15:32:25
11 Apr 2025
Promising Preliminary Results of Phase 1 Study
Promising Preliminary Results of Phase 1 Study
18/03/25
10:38:02
18 Mar 2025
Placing to raise £250,000
Placing to raise £250,000
03/02/25
07:00:06
3 Feb 2025
IB Expands Distribution with Blackford
IB Expands Distribution with Blackford
22/01/25
07:00:05
22 Jan 2025
Operations Update
Operations Update
10/01/25
07:49:29
10 Jan 2025
IB and Prism Secure First Installation
IB and Prism Secure First Installation
20/11/24
07:00:02
20 Nov 2024
Imaging Biometrics Expands Distribution
Imaging Biometrics Expands Distribution
19/11/24
11:27:03
19 Nov 2024
Board Changes
Board Changes
05/11/24
07:00:02
5 Nov 2024
New Patent Application and Trading Update
New Patent Application and Trading Update
15/10/24
10:28:36
15 Oct 2024
Holding(s) in Company
Holding(s) in Company
15/10/24
07:00:09
15 Oct 2024
IQ-AI Issues Letter to Shareholders
IQ-AI Issues Letter to Shareholders
14/10/24
12:08:15
14 Oct 2024
Holding(s) in Company
Holding(s) in Company
14/10/24
12:05:29
14 Oct 2024
PDMR dealing and TR1 announcement
PDMR dealing and TR1 announcement
11/10/24
10:42:37
11 Oct 2024
Acquisition of Interest by Braveheart
Acquisition of Interest by Braveheart
13/08/24
14:53:23
13 Aug 2024
Half-year Report
Half-year Report
25/06/24
09:59:49
25 Jun 2024
IB Opens Expanded Access Program
IB Opens Expanded Access Program
14/06/24
08:38:49
14 Jun 2024
Clinical Trial Updates
Clinical Trial Updates
29/05/24
15:08:33
29 May 2024
Result of AGM
Result of AGM
23/05/24
07:00:12
23 May 2024
Major East Coast Health System Chooses IB Nimble
Major East Coast Health System Chooses IB Nimble
20/05/24
07:10:27
20 May 2024
Second FDA Rare Pediatric Disease Designation
Second FDA Rare Pediatric Disease Designation
17/05/24
07:00:08
17 May 2024
IB Software Enhances Clinical Decision-Making
IB Software Enhances Clinical Decision-Making
10/05/24
08:15:34
10 May 2024
Rare Pediatric Disease Designation Granted to GaM
Rare Pediatric Disease Designation Granted to GaM
02/05/24
12:47:42
2 May 2024
IB Announces Expanded Access Program for GaM
IB Announces Expanded Access Program for GaM
29/04/24
15:26:10
29 Apr 2024
Publication of Annual Report
Publication of Annual Report
05/03/24
07:00:11
5 Mar 2024
Grant of Options
Grant of Options
01/03/24
08:22:06
1 Mar 2024
Holding(s) in Company
Holding(s) in Company
01/03/24
08:20:36
1 Mar 2024
Holding(s) in Company
Holding(s) in Company
26/02/24
07:00:03
26 Feb 2024
Result of Broker Option and Total Voting Rights
Result of Broker Option and Total Voting Rights
22/02/24
07:00:06
22 Feb 2024
Placing and Broker Option
Placing and Broker Option
09/02/24
12:49:51
9 Feb 2024
FDA Application Update
FDA Application Update
02/02/24
08:39:32
2 Feb 2024
IB awarded a $100,000 grant
IB awarded a $100,000 grant
22/01/24
10:05:43
22 Jan 2024
Holding(s) in Company
Holding(s) in Company
15/01/24
07:01:00
15 Jan 2024
Director Dealings and Conversion of CLNs
Director Dealings and Conversion of CLNs
15/01/24
07:00:05
15 Jan 2024
Holding(s) in Company
Holding(s) in Company
10/01/24
07:00:01
10 Jan 2024
IB Launching an Expanded Access Program for GaM
IB Launching an Expanded Access Program for GaM
19/12/23
14:29:45
19 Dec 2023
Imaging Biometrics granted FDA “Fast-Track”
Imaging Biometrics granted FDA “Fast-Track”
05/12/23
10:58:08
5 Dec 2023
IQ-AI Announces Positive Interim Phase 1 Results
IQ-AI Announces Positive Interim Phase 1 Results
20/11/23
13:42:56
20 Nov 2023
Holding(s) in Company
Holding(s) in Company
09/11/23
11:38:50
9 Nov 2023
Director Dealing and Conversion of CLNs
Director Dealing and Conversion of CLNs
08/11/23
10:59:44
8 Nov 2023
Application for Pediatric Rare Disease Designation
Application for Pediatric Rare Disease Designation
06/11/23
13:02:11
6 Nov 2023
Holding(s) in Company
Holding(s) in Company
18/10/23
14:29:47
18 Oct 2023
Update Regarding Imaging Biometrics LLC
Update Regarding Imaging Biometrics LLC
13/10/23
08:55:09
13 Oct 2023
IB Letter to Shareholders
IB Letter to Shareholders
09/10/23
07:00:14
9 Oct 2023
Orphan Drug Status to GaM and Total Voting Rights
Orphan Drug Status to GaM and Total Voting Rights
03/10/23
11:30:18
3 Oct 2023
Holding(s) in Company
Holding(s) in Company
19/09/23
14:32:20
19 Sept 2023
IQ-AI shares cease trading on the OTCQB
IQ-AI shares cease trading on the OTCQB
Showing 1–50 of 105 announcements
1
2
3
Next